Search Results - "Boetes, C"

Breast MRI: guidelines from the European Society of Breast Imaging by Mann, R. M., Kuhl, C. K., Kinkel, K., Boetes, C.

“…The aim of breast MRI is to obtain a reliable evaluation of any lesion within the breast. It is currently always used as an adjunct to the standard diagnostic…”
Get full text

Breast MRI: guidelines from the European Society of Breast Imaging by Mann, R M, Kuhl, C K, Kinkel, K, Boetes, C

Get full text

impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast by Mann, R. M, Loo, C. E, Wobbes, T, Bult, P, Barentsz, J. O, Gilhuijs, K. G. A, Boetes, C

“…Re-excision rates after breast conserving surgery (BCS) of invasive lobular carcinoma (ILC) are high. Preoperative breast MRI has the potential to reduce…”
Get full text

Volumetric breast density estimation from full-field digital mammograms by van Engeland, S., Snoeren, P.R., Huisman, H., Boetes, C., Karssemeijer, N.

“…A method is presented for estimation of dense breast tissue volume from mammograms obtained with full-field digital mammography (FFDM). The thickness of dense…”
Get full text

Update on Screening Breast MRI in High-Risk Women by Boetes, C., MD, PhD

“…Breast cancer is the most common cancer in women. One in 8 women develops breast cancer and approximately 30% of all affected women die of the disease. By…”
Get full text

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI by Veltman, J., Mann, R., Kok, T., Obdeijn, I. M., Hoogerbrugge, N., Blickman, J. G., Boetes, C.

“…The appearance of malignant lesions in BRCA1 and BRCA2 mutation carriers (BRCA-MCs) on mammography and magnetic resonance imaging (MRI) was evaluated. Thus, 29…”
Get full text

Update on Screening Breast MRI in High-Risk Women by Boetes, C., MD, PhD

“…Breast cancer is the most common cancer in women. One in 8 women develops breast cancer and approximately 30% of all affected women die of the disease. By…”
Get full text

Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions by Veltman, J., Stoutjesdijk, M., Mann, R., Huisman, H. J., Barentsz, J. O., Blickman, J. G., Boetes, C.

“…The value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in characterizing breast lesions on magnetic resonance…”
Get full text

The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast by Mann, R.M, Veltman, J, Barentsz, J.O, Wobbes, T, Blickman, J.G, Boetes, C

“…Abstract Aims Invasive lobular carcinoma of the breast (ILC) is known to be substantially underestimated by mammography, which makes correct planning of…”
Get full text

Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer by Stoutjesdijk, Mark J., Boetes, Carla, Jager, Gerrit J., Beex, Louk, Bult, Peter, Hendriks, Jan H. C. L., Laheij, Robert J. F., Massuger, Leon, van Die, Lya E., Wobbes, Theo, Barentsz, Jelle O.

“…Background: Although breast cancer screening is recommended to start at a younger age for women with a hereditary risk of breast cancer, the sensitivity of…”
Get full text

High Prevalence of Premalignant Lesions in Prophylactically Removed Breasts From Women at Hereditary Risk for Breast Cancer by HOOGERBRUGGE, N, BULT, P, DE WIDT-LEVERT, L. M, BEEX, L. V, KIEMENEY, L. A, LIGTENBERG, M. J. L, MASSUGER, L. F, BOETES, C, MANDERS, P, BRUNNER, H. G

“…Women with a hereditary predisposition for breast cancer have an extremely high risk of developing invasive breast carcinoma, and many women consider…”
Get full text

5115 POSTER Neo-adjuvant Chemotherapy in Breast Cancer; the Possibility of Response Evaluation and Prediction of Response Treatment Using the Internal Mammary Vessels on MR Mammography by Schipper, R, Lobbes, M, Smidt, M, Boetes, C

Get full text

70 Retrospective Comparison of the Accuracy of two Different Computer Aided Detection Systems for Detecting Malignant Lesions on Mammography by Lobbes, M, Smidt, M, Keymeulen, K, Beets-Tan, R.G, Wildberger, J, Boetes, C

Get full text

MRI for breast conservation surgery by Mann, RM, Boetes, C

“…Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of…”
Get full text

2102 POSTER Bilateral Analysis of the Vascular Surface of the Internal Mammary Arteries and Veins in Patients With Breast Cancer on Magnetic Resonance Mammography (MRM) by Schipper, R, Dikmans, R, Lobbes, M, Smidt, M, Boetes, C

Get full text

Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent by Boetes, C, Mus, R D, Holland, R, Barentsz, J O, Strijk, S P, Wobbes, T, Hendriks, J H, Ruys, S H

“…To evaluate the comparative accuracy of magnetic resonance (MR) imaging relative to mammography and ultrasonography (US) for assessing the extent of breast…”
Get more information

173 Flat Epithelial Atypia: Its Management and Outcome in Four Dutch Teaching Hospitals by Ghuijs, P, Boetes, C, van Deurzen, C.H.M, van der Ent, F.W, Heuts, E.M, Strobbe, L.J.A, van de Vijver, K.K.B.T, de Vries, B, Wauters, C.A.P, Smidt, M.L

Get full text

5142 POSTER Immediate Breast Reconstruction (IBR) After Skin-sparing Mastectomy (SSM) Does Not Increase the Risk of Loco Regional Recurrence or Distant Metastases by van Mierlo, D, Schipper, R, van Waardhuizen, O, Martens, M, Peeters, W, Boetes, C, Heuts, E, Smidt, M

Get full text

The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited by Hoogerbrugge, N., Kamm, Y. J. L., Bult, P., Landsbergen, K. M., Bongers, E. M. H. F., Brunner, H. G., Bonenkamp, H. J., de Hullu, J. A., Ligtenberg, M. J. L., Boetes, C.

“…Purpose: To assess the false-positive rate of breast cancer surveillance by magnetic resonance imaging (MRI) in BRCA mutation carriers and the impact of an…”
Get full text

The evaluation of women with familial risk of breast cancer by Boetes, C

“…The life-time risk for getting breast cancer in The Netherlands is about 11%. About 5% to 10% of these cases are hereditary. Because the value of mammography…”
Get more information